Aim: To report a study protocol that refines then examines feasibility, preliminary efficacy, and satisfaction of ADHERE, an intervention using motivational interviewing and brief cognitive behavioral therapy as a mechanism for goal-oriented systematic patient education to promote symptom management and adherence among cancer patients prescribed oral anti-cancer agents. Background: Cancer treatment with oral anti-cancer agents shifts responsibility for managing treatment from clinicians in supervised cancer centers to patients and their caregivers. Thus, a need exists to standardize start-of-care for support patient self-management of care at home. Design: A two-phase quasi-experimental sequential design with repeated measures. Methods: Six...
Background: Many people with cancer experience pain at the end of life. Family carers play a signifi...
Aims and objectives: The World Health Organization has indicated medication adherence is a global pr...
Background: The use of oral systemic anti-cancer treatment (SACT) has increased significantly in rec...
Aim: To report a study protocol that refines then examines feasibility, preliminary efficacy, and sa...
Background: The use of oral chemotherapy agents to treat cancer has increased. Patients are responsi...
Aim: The aim of this study was to report a study protocol that examines feasibility, preliminary eff...
Purpose: The purpose of this quantitative descriptive research study is to determine the baseline me...
This study was designed to develop and test a system to monitor adherence with non-hormonal oral che...
Background: In the United States, 1.7 million new cases of cancer were diagnosed in 2018 and proved ...
Background and objective: Oral anti-cancer treatments have expanded rapidly over the last years. Whi...
The expansion of oral chemotherapy treatment options reveals the need to improve strategies for asse...
OBJECTIVE: Given the increasing use of oral antineoplastic agents in cancer management, patient adhe...
Oral oncolytics continue to come to market at an unprecedented pace. Traditionally, chemotherapy was...
BACKGROUND: Oral anticancer medications offer state-of-the-art cancer treatment with the convenience...
BACKGROUND: Over the past 10 years, molecular-based and targeted therapies in oral forms have emerge...
Background: Many people with cancer experience pain at the end of life. Family carers play a signifi...
Aims and objectives: The World Health Organization has indicated medication adherence is a global pr...
Background: The use of oral systemic anti-cancer treatment (SACT) has increased significantly in rec...
Aim: To report a study protocol that refines then examines feasibility, preliminary efficacy, and sa...
Background: The use of oral chemotherapy agents to treat cancer has increased. Patients are responsi...
Aim: The aim of this study was to report a study protocol that examines feasibility, preliminary eff...
Purpose: The purpose of this quantitative descriptive research study is to determine the baseline me...
This study was designed to develop and test a system to monitor adherence with non-hormonal oral che...
Background: In the United States, 1.7 million new cases of cancer were diagnosed in 2018 and proved ...
Background and objective: Oral anti-cancer treatments have expanded rapidly over the last years. Whi...
The expansion of oral chemotherapy treatment options reveals the need to improve strategies for asse...
OBJECTIVE: Given the increasing use of oral antineoplastic agents in cancer management, patient adhe...
Oral oncolytics continue to come to market at an unprecedented pace. Traditionally, chemotherapy was...
BACKGROUND: Oral anticancer medications offer state-of-the-art cancer treatment with the convenience...
BACKGROUND: Over the past 10 years, molecular-based and targeted therapies in oral forms have emerge...
Background: Many people with cancer experience pain at the end of life. Family carers play a signifi...
Aims and objectives: The World Health Organization has indicated medication adherence is a global pr...
Background: The use of oral systemic anti-cancer treatment (SACT) has increased significantly in rec...